To better understand the risks of this rare functional polymorphism on other cancers, we then systematically evaluated prevalence of the MITF(E318K) variant in multiple cancer cohorts using germline whole-exome sequence data from the TCGA panel and from several genetically-enriched cohorts to validate these associations (Table 1). Here, MITF is linked to cancer.